Thursday, October 14, 2021 7:25:18 AM
Perhaps this already made the rounds here, but I’ve been unable to find traction in discussing this elsewhere.
Has anyone seen the recent Discovery Report magazine issue “Antivirals for The Future”, published by c&en in Q3 2021? The magazine features an article titled “8 experts weigh in on the future of antivirals.” The first expert featured is Dr. Chandra and includes this excerpt from the author:
This is in reference to an antibody targeting HIV discovered as a result of AI. While Chandra is quoted several times in the article, this except is not a direct quote — however, it is presumably a statement made by Chandra (and likely approved by him before publication). The author goes on to distinguish this HIV antibody from ENZC’s antibody which targets covid, saying the company has plans to start clinical trials on the most promising covid mAb candidates early next year.
Given what we know, I find this to be a peculiar statement at odds with what we’ve been told. I’m curious to hear anyone’s thoughts.
(FWIW, I emailed the publication asking for clarification.)
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
FEATURED DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • Nov 7, 2024 2:16 PM
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • Nov 7, 2024 8:48 AM
FEATURED SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • Nov 7, 2024 7:00 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM